

Dubai's dedicated science, healthcare, pharmaceutical and biotech free zone (formerly DuBiotech), part of TECOM Group, home to anchor tenants such as AstraZeneca, Himalaya and Jotun. It has evolved into a mixed-use community pairing that R&D employment cluster with affordable mid
Dubai Science Park offers some of the better gross rental yields in Dubai (commonly quoted in the 6.5-8% band on studios and 1-beds) thanks to a built-in tenant base from its science and pharma employers and consistently high occupancy. Entry prices are affordable relative to Downtown and Marina, and off-plan phases give exposure to further appreciation, but investors should note the community has no direct metro access and is apartment-dominated, so it suits income and value plays more than trophy-asset buyers.
It is a solid income play: gross rental yields typically run 6.5-8% on apartments with occupancy around 90%+, and area guides reported roughly 12-15% capital appreciation in 2024, though growth is expected to moderate in 2025-2026.
It best suits yield-focused investors and mid-income end-users seeking affordable studios and 1-2 bedroom apartments with reliable rental demand, particularly those working in or near the Al Barsha, JVC and Motor City corridor.
It is Dubai's dedicated science, healthcare and biotech free zone (formerly DuBiotech) under TECOM Group, hosting tenants like AstraZeneca and Himalaya, and is now a freehold mixed-use community combining that employment hub with modern residential apartments.


